Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rough Draft Ventures is a student-powered venture investing program associated with General Catalyst that backs university-affiliated founders at very early stages. The organization focuses broadly on technology startups rather than operating as a drug developer, biopharma company, or healthcare services provider. It provides small initial investments, typically through founder-friendly SAFE structures, along with access to a student fellow network, mentorship, and the broader General Catalyst ecosystem. Rough Draft Ventures appears to function primarily as an early-stage investor and talent network for student entrepreneurs across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rough Draft Ventures.